Found 33 hits of ec50 for UniProtKB: Q9GZT9 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50607013
(CHEMBL5219134)Show SMILES OC(=O)CNC(=O)c1cnc(NS(=O)(=O)Cc2ccccc2)nc1O | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50607011
(CHEMBL5219277)Show SMILES OC(=O)CNC(=O)c1cnc(NS(=O)(=O)c2ccc(cc2)-c2ccccc2)nc1O | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50607009
(CHEMBL5218673)Show SMILES COc1ccc(cc1)S(=O)(=O)Nc1ncc(C(=O)NCC(O)=O)c(O)n1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 190 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50607010
(CHEMBL5218720)Show SMILES OC(=O)CNC(=O)c1cnc(NS(=O)(=O)c2cccc(Cl)c2)nc1O | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.25E+3 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286248
(CHEMBL4168030)Show InChI InChI=1S/C14H18N4O4/c1-2-3-4-5-9-6-10(19)12(13-16-8-17-18(9)13)14(22)15-7-11(20)21/h6,8,19H,2-5,7H2,1H3,(H,15,22)(H,20,21) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.20E+3 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50607012
(CHEMBL5220549)Show SMILES OC(=O)CNC(=O)c1cnc(NS(=O)(=O)c2ccc(Cl)c(Cl)c2)nc1O | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.46E+3 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286228
(CHEMBL4174643)Show SMILES OC(=O)CNC(=O)c1c(O)cc(-c2cccc(Cl)c2)n2ncnc12 Show InChI InChI=1S/C15H11ClN4O4/c16-9-3-1-2-8(4-9)10-5-11(21)13(14-18-7-19-20(10)14)15(24)17-6-12(22)23/h1-5,7,21H,6H2,(H,17,24)(H,22,23) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286072
(CHEMBL4164403)Show InChI InChI=1S/C15H18N4O4/c20-11-6-10(9-4-2-1-3-5-9)19-14(17-8-18-19)13(11)15(23)16-7-12(21)22/h6,8-9,20H,1-5,7H2,(H,16,23)(H,21,22) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.70E+3 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50607007
(CHEMBL5219872)Show SMILES OC(=O)CNC(=O)c1cnc(NS(=O)(=O)c2ccc(cc2)C(F)(F)F)nc1O | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 4.91E+3 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50607006
(CHEMBL5218506)Show SMILES OC(=O)CNC(=O)c1cnc(NS(=O)(=O)c2ccc(Cl)cc2)nc1O | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 5.54E+3 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286071
(CHEMBL4166742)Show SMILES Cl.OC(=O)CNC(=O)c1c(O)cc(CCc2ccccc2)n2ncnc12 Show InChI InChI=1S/C17H16N4O4/c22-13-8-12(7-6-11-4-2-1-3-5-11)21-16(19-10-20-21)15(13)17(25)18-9-14(23)24/h1-5,8,10,22H,6-7,9H2,(H,18,25)(H,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 5.70E+3 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286233
(CHEMBL4175892)Show InChI InChI=1S/C13H16N4O4/c1-2-3-4-8-5-9(18)11(12-15-7-16-17(8)12)13(21)14-6-10(19)20/h5,7,18H,2-4,6H2,1H3,(H,14,21)(H,19,20) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 5.80E+3 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286068
(CHEMBL4171201)Show SMILES Cl.OC(=O)CNC(=O)c1c(O)cc(CCc2ccc(F)cc2)n2ncnc12 Show InChI InChI=1S/C17H15FN4O4/c18-11-4-1-10(2-5-11)3-6-12-7-13(23)15(16-20-9-21-22(12)16)17(26)19-8-14(24)25/h1-2,4-5,7,9,23H,3,6,8H2,(H,19,26)(H,24,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 5.80E+3 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286250
(CHEMBL4159751)Show SMILES OC(=O)CNC(=O)c1c(O)cc(-c2cccc(Cl)c2)c2ncnn12 Show InChI InChI=1S/C15H11ClN4O4/c16-9-3-1-2-8(4-9)10-5-11(21)13(15(24)17-6-12(22)23)20-14(10)18-7-19-20/h1-5,7,21H,6H2,(H,17,24)(H,22,23) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 5.80E+3 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50431015
(CHEMBL2338329 | US10889546, FG-4592 | US9115085, C...)Show SMILES Cc1nc(C(=O)NCC(O)=O)c(O)c2ccc(Oc3ccccc3)cc12 Show InChI InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
PDB
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 6.11E+3 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50607008
(CHEMBL5218607)Show SMILES OC(=O)CNC(=O)c1cnc(NS(=O)(=O)c2ccc(Br)cc2)nc1O | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 7.97E+3 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50607005
(CHEMBL5219927)Show SMILES Cc1ccc(cc1)S(=O)(=O)Nc1ncc(C(=O)NCC(O)=O)c(O)n1 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 9.27E+3 | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.129007
BindingDB Entry DOI: 10.7270/Q2CJ8JKT |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286251
(CHEMBL4167844)Show InChI InChI=1S/C14H18N4O4/c1-2-3-4-5-9-7-18-13(16-8-17-18)11(12(9)21)14(22)15-6-10(19)20/h7-8,21H,2-6H2,1H3,(H,15,22)(H,19,20) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 9.30E+3 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286231
(CHEMBL4175056)Show SMILES Cl.OC(=O)CNC(=O)c1c(O)cc(-c2ccccc2)n2ncnc12 Show InChI InChI=1S/C15H12N4O4/c20-11-6-10(9-4-2-1-3-5-9)19-14(17-8-18-19)13(11)15(23)16-7-12(21)22/h1-6,8,20H,7H2,(H,16,23)(H,21,22) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286263
(CHEMBL4167657)Show SMILES Cl.OC(=O)CNC(=O)c1c(O)cc(CCc2ccccc2)c2ncnn12 Show InChI InChI=1S/C17H16N4O4/c22-13-8-12(7-6-11-4-2-1-3-5-11)16-19-10-20-21(16)15(13)17(25)18-9-14(23)24/h1-5,8,10,22H,6-7,9H2,(H,18,25)(H,23,24) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.30E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286230
(CHEMBL4171371)Show InChI InChI=1S/C12H14N4O4/c1-2-3-7-4-8(17)10(11-14-6-15-16(7)11)12(20)13-5-9(18)19/h4,6,17H,2-3,5H2,1H3,(H,13,20)(H,18,19) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286232
(CHEMBL4173606)Show SMILES Cl.OC(=O)CNC(=O)c1c(O)cc(-c2ccccc2)c2ncnn12 Show InChI InChI=1S/C15H12N4O4/c20-11-6-10(9-4-2-1-3-5-9)14-17-8-18-19(14)13(11)15(23)16-7-12(21)22/h1-6,8,20H,7H2,(H,16,23)(H,21,22) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286070
(CHEMBL4166512)Show SMILES Cl.Cc1nc2c(C(=O)NCC(O)=O)c(O)cc(CCc3ccccc3)n2n1 Show InChI InChI=1S/C18H18N4O4/c1-11-20-17-16(18(26)19-10-15(24)25)14(23)9-13(22(17)21-11)8-7-12-5-3-2-4-6-12/h2-6,9,23H,7-8,10H2,1H3,(H,19,26)(H,24,25) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286224
(CHEMBL4162891)Show InChI InChI=1S/C15H18N4O4/c20-11-6-10(9-4-2-1-3-5-9)14-17-8-18-19(14)13(11)15(23)16-7-12(21)22/h6,8-9,20H,1-5,7H2,(H,16,23)(H,21,22) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM102348
(US10562854, No. A41 | US8536181, A41 | US9278930, ...)Show SMILES CC(C)(C)OC(=O)N1CCN(Cc2ccn(Cc3ccc(Cl)cc3)c(=O)c2O)CC1 Show InChI InChI=1S/C22H28ClN3O4/c1-22(2,3)30-21(29)25-12-10-24(11-13-25)15-17-8-9-26(20(28)19(17)27)14-16-4-6-18(23)7-5-16/h4-9,27H,10-15H2,1-3H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a |
Janssen Pharmaceutical Research& Development, LLC
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in HEK293 cells assessed as VEGF release by immunoassay |
J Med Chem 56: 9369-402 (2014)
Article DOI: 10.1021/jm400386j
BindingDB Entry DOI: 10.7270/Q290258T |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286245
(CHEMBL4163070)Show SMILES OC(=O)CNC(=O)c1nc(Cl)c2cc(Oc3ccccc3)ccc2c1O Show InChI InChI=1S/C18H13ClN2O5/c19-17-13-8-11(26-10-4-2-1-3-5-10)6-7-12(13)16(24)15(21-17)18(25)20-9-14(22)23/h1-8,24H,9H2,(H,20,25)(H,22,23) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286249
(CHEMBL4159929)Show InChI InChI=1S/C13H16N4O4/c1-3-7-8(4-2)17-12(15-6-16-17)10(11(7)20)13(21)14-5-9(18)19/h6,20H,3-5H2,1-2H3,(H,14,21)(H,18,19) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 2.10E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286246
(CHEMBL4159695)Show InChI InChI=1S/C10H9N3O4/c14-7-2-1-6-3-4-12-13(6)9(7)10(17)11-5-8(15)16/h1-4,14H,5H2,(H,11,17)(H,15,16) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >3.00E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286229
(CHEMBL4167612)Show InChI InChI=1S/C10H9N3O4/c14-6-1-3-13-4-2-11-9(13)8(6)10(17)12-5-7(15)16/h1-4,14H,5H2,(H,12,17)(H,15,16) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >3.00E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286227
(CHEMBL4160770)Show InChI InChI=1S/C9H8N4O4/c14-5-1-2-6-11-4-12-13(6)8(5)9(17)10-3-7(15)16/h1-2,4,14H,3H2,(H,10,17)(H,15,16) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >3.00E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286069
(CHEMBL4174815)Show InChI InChI=1S/C9H8N4O4/c14-5-1-2-13-8(11-4-12-13)7(5)9(17)10-3-6(15)16/h1-2,4,14H,3H2,(H,10,17)(H,15,16) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >3.00E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50286247
(CHEMBL4164159)Show InChI InChI=1S/C9H8N4O4/c14-5-1-2-13-4-11-12-8(13)7(5)9(17)10-3-6(15)16/h1-2,4,14H,3H2,(H,10,17)(H,15,16) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | >3.00E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | |
Egl nine homolog 1
(Homo sapiens (Human)) | BDBM50193145
(2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido)ac...)Show InChI InChI=1S/C12H9ClN2O4/c13-11-7-4-2-1-3-6(7)10(18)9(15-11)12(19)14-5-8(16)17/h1-4,18H,5H2,(H,14,19)(H,16,17) | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| n/a | n/a | n/a | n/a | 7.90E+4 | n/a | n/a | n/a | n/a |
Japan Tobacco Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO release after 24 hrs by ELISA |
ACS Med Chem Lett 8: 1320-1325 (2017)
Article DOI: 10.1021/acsmedchemlett.7b00404
BindingDB Entry DOI: 10.7270/Q21N83N8 |
More data for this
Ligand-Target Pair | 
3D Structure (crystal) |
Search and Browse
